The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Open accessAbstract
We used cross-linking and immunoprecipitation coupled with high-throughput sequencing to identify binding sites in 6,304 genes as the brain RNA targets for TDP-43, an RNA binding protein that, when mutated, causes amyotrophic lateral sclerosis. Massively parallel sequencing and splicing-sensitive junction arrays revealed that levels of 601 mRNAs were changed (including Fus (Tls), progranulin and other transcripts encoding neurodegenerative disease-associated proteins) and 965 altered splicing events were detected (including in sortilin, the receptor for progranulin) following depletion of TDP-43 from mouse adult brain with antisense oligonucleotides. RNAs whose levels were most depleted by reduction in TDP-43 were derived from genes with very long introns and that encode proteins involved in synaptic activity. Lastly, we found that TDP-43 autoregulates its synthesis, in part by directly binding and enhancing splicing of an intron in the 3' untranslated region of its own transcript, thereby triggering nonsense-mediated RNA degradation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both the ALS-associated mutations and the changes in wild-type TDP43 expression alter a large programme of alternative exons in mutant mice170,174,175.”
From The neurogenetics of alternative splicing (2016) · cites this paper as [170]
In the citing paper
“However, less than a quarter of affected exons are shared between the transgenic and RNA interference-depletion mouse models.”
From The neurogenetics of alternative splicing (2016) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
A gene atlas of the mouse and human protein-encoding transcriptomes
Su, A. I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K. A., Block, D., Zhang, J., Soden, R., Hayakawa, M., Kreiman, G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400782101 · Cited by 3,475
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E., et al. (2008) · Science · doi:10.1126/science.1154584 · Cited by 2,630
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,625
Cited by
Sorted by citations
Items 401–500 of 1,000
TDP43 and RNA instability in amyotrophic lateral sclerosis
Weskamp, K., & Barmada, S. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.015 · Cited by 68
Pereira, G., Sánchez, L., Schaughency, P., Rubio-Roldán, A., Choi, J. A., Planet, E., Batra, R., Turelli, P., Trono, D., Ostrow, L. W., et al. (2018) · Mobile DNA · doi:10.1186/s13100-018-0138-z · Cited by 70
Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains
Yin, P., Guo, X., Yang, W., Yan, S., Yang, S., Zhao, T., Sun, Q., Liu, Y., Li, S., & Li, X. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01979-0 · Cited by 65
RNA metabolism in ALS: When normal processes become pathological
Droppelmann, C. A., Campos‐Melo, D., Ishtiaq, M., Volkening, K., & Strong, M. J. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.881377 · Cited by 63
TDP-43 regulates the mammalian spinogenesis through translational repression of Rac1
Majumder, P., Chen, Y., Bose, J. K., Wu, C., Cheng, W.-C., Cheng, S., Fang, Y.-H., Chen, Y., Tsai, K., Lien, C., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1006-4 · Cited by 69
Wang, G., Yang, H., Yan, S., Wang, C.-E., Liu, X., Zhao, B., Ouyang, Z., Yin, P., Liu, Z., Zhao, Y., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0036-5 · Cited by 64
Mihevc, S. P., Baralle, M., Buratti, E., & Rogelj, B. (2016) · Scientific Reports · doi:10.1038/srep33996 · Cited by 67
Matamala, J. M., Arias‐Carrasco, R., Sanchez, C., Uhrig, M., Bargsted, L., Matus, S., Maracaja‐Coutinho, V., Abarzúa, S., van Zundert, B., Verdugo, R. J., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.12.020 · Cited by 64
Dyer, M. S., Reale, L. A., Lewis, K. E. A., Walker, A. K., Dickson, T. C., Woodhouse, A., & Blizzard, C. A. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15214 · Cited by 59
Nag, S., & Schneider, J. A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00846-7 · Cited by 69
TDP-43 Autoregulation: Implications for Disease
Budini, M., & Buratti, E. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9573-8 · Cited by 57
Genomic editing opens new avenues for zebrafish as a model for neurodegeneration
Schmid, B., & Haass, C. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12460 · Cited by 69
Melikishvili, M., Chariker, J. H., Rouchka, E. C., & Fondufe‐Mittendorf, Y. N. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.43 · Cited by 64
TDP-43 induces p53-mediated cell death of cortical progenitors and immature neurons
Vogt, M. A., Ehsaei, Z., Knuckles, P., Higginbottom, A., Helmbrecht, M. S., Kunath, T., Eggan, K. C., Williams, L. A., Shaw, P. J., Wurst, W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26397-2 · Cited by 61
Sorting receptor sortilin—a culprit in cardiovascular and neurological diseases
Carlo, A.-S., Nykjaer, A., & Willnow, T. E. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1152-3 · Cited by 56
Li, Y., Collins, M. A., An, J., Geiser, R., Tegeler, T. J., Tsantilas, K. A., Garcia, K., Pirrotte, P., & Bowser, R. P. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.047 · Cited by 62
TDP-43 prevents endogenous RNAs from triggering a lethal RIG-I-dependent interferon response
Dunker, W., Ye, X., Zhao, Y., Liu, N., Richardson, A., & Karijolich, J. J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108976 · Cited by 64
Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport
Štalekar, M., Yin, X., Rebolj, K., Darovic, S., Troakes, C., Mayr, M., Shaw, C. E., & Rogelj, B. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.046 · Cited by 64
Clark, J. A., Yeaman, E. J., Blizzard, C. A., Chuckowree, J. A., & Dickson, T. C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00204 · Cited by 66
TDP-43 and Cytoskeletal Proteins in ALS
Oberstadt, M., Claßen, J., Arendt, T., & Holzer, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0543-1 · Cited by 60
The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis
Nguyen, T. M., Kabotyanski, E. B., Reineke, L. C., Shao, J., Xiong, F., Lee, J.-H., Dubrulle, J., Johnson, H. L., Stossi, F., Tsoi, P. S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1176 · Cited by 65
Genetics of Familial Amyotrophic Lateral Sclerosis
Emily, F., Joanna, J., Cooper‐Knock, J., Pamela, J., & Kirby, J. (2012) · InTech eBooks · doi:10.5772/32498 · Cited by 60
From nucleation to widespread propagation: A prion-like concept for ALS
Maniecka, Z., & Polymenidou, M. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.032 · Cited by 65
Self-citationBennett, C. L., Dastidar, S. G., Ling, S., Malik, B., Ashe, T. D., Wadhwa, M., Miller, D. B., Lee, C., Mitchell, M. B., van Es, M. A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1852-9 · Cited by 66
Self-citationTDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination
Ho, W. Y., Chang, J., Lim, K., Cazenave‐Gassiot, A., Nguyen, A. T., Foo, J. C., Muralidharan, S., Viera-Ortiz, A., Ong, S. J. M., Hor, J. H., et al. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.201910213 · Cited by 61
Self-citationSorting through the extensive and confusing roles of sortilin in metabolic disease
Mitok, K. A., Keller, M. P., & Attie, A. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100243 · Cited by 60
Reversible Behavioral Phenotypes in a Conditional Mouse Model of TDP-43 Proteinopathies
Alfieri, J. A., Pino, N. S., & Igaz, L. M. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1918-14.2014 · Cited by 60
The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis
Fukunaga, K., Shinoda, Y., & Tagashira, H. (2014) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2014.12.012 · Cited by 60
Li, W., Reeb, A. N., Lin, B., Subramanian, P., Fey, E. E., Knoverek, C. R., French, R. L., Bigio, E. H., & Ayala, Y. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.753913 · Cited by 62
TDP-43 and FUS–structural insights into RNA recognition and self-association
Loughlin, F. E., & Wilce, J. A. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.07.012 · Cited by 62
Transcriptome-wide analysis of protein–RNA interactions using high-throughput sequencing
Milek, M., Wyler, E., & Landthaler, M. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.12.001 · Cited by 64
Gelon, P. A., Dutchak, P. A., & Sephton, C. F. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1000183 · Cited by 64
RNA dysregulation in neurodegenerative diseases
Li, Y., & Sun, S. (2025) · The EMBO Journal · doi:10.1038/s44318-024-00352-6 · Cited by 65
Honda, D., Ishigaki, S., Iguchi, Y., Fujioka, Y., Udagawa, T., Masuda, A., Ohno, K., Katsuno, M., & Sobue, G. (2013) · FEBS Open Bio · doi:10.1016/j.fob.2013.11.001 · Cited by 61
Takanashi, K., & Yamaguchi, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.115 · Cited by 59
TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1
He, F., Krans, A., Freibaum, B. D., Taylor, J. P., & Todd, P. K. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu216 · Cited by 62
RNA-binding protein CPEB1 remodels host and viral RNA landscapes
Batra, R., Stark, T. J., Clark, A. E., Belzile, J.-P., Wheeler, E. C., Yee, B. A., Huang, H., Gelboin-Burkhart, C. A., Huelga, S. C., Aigner, S., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3310 · Cited by 59
Self-citationProtein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum
Shahheydari, H., Ragagnin, A., Walker, A. K., Toth, R. P., Vidal, M., Jagaraj, C. J., Perri, E. R., Konopka, A., Sultana, J. M., & Atkin, J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00119 · Cited by 61
Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
Ranganathan, R., Haque, S., Coley, K., Shepheard, S. R., Cooper‐Knock, J., & Kirby, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00684 · Cited by 62
Cell environment shapes TDP-43 function with implications in neuronal and muscle disease
Šušnjar, U., Škrabar, N., Brown, A., Abbassi, Y., Phatnani, H. P., Phatnani, H. P., Fratta, P., Kwan, J. Y., Sareen, D., Broach, J. R., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03253-8 · Cited by 57
López‐Erauskin, J., Bravo‐Hernández, M., Presa, M. F., Baughn, M. W., Melamed, Z., Beccari, M. S., Quadros, A. R. A. D. A., Arnold-García, O., Zuberi, A. R., Ling, K., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01496-0 · Cited by 58
Self-citationThe sense of antisense therapies in ALS
Daele, S. H. V., Masrori, P., Damme, P. V., & Bosch, L. V. D. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.12.003 · Cited by 61
RNAmotifs: prediction of multivalent RNA motifs that control alternative splicing
Cereda, M., Pozzoli, U., Rot, G., Juvan, P., Schweitzer, A. C., Clark, T. A., & Ule, J. (2014) · Genome biology · doi:10.1186/gb-2014-15-1-r20 · Cited by 58
Progranulin and TDP-43: Mechanistic Links and Future Directions
Kumar‐Singh, S. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9625-0 · Cited by 56
RNA‐binding proteins implicated in neurodegenerative diseases
Cookson, M. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1397 · Cited by 58
Sun, Y., Bao, Y., Han, W., Song, F., Shen, X., Zhao, J., Zuo, J., Saffen, D. W., Chen, W., Wang, Z., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx508 · Cited by 57
Parkin in Parkinson’s Disease and Cancer: a Double-Edged Sword
Wahabi, K., Perwez, A., & Rizvi, M. M. A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0879-1 · Cited by 58
ALS and FTD: Where RNA metabolism meets protein quality control
Mandrioli, J., Mediani, L., Alberti, S., & Carra, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.06.003 · Cited by 63
Recent Advances in the Genetics of the ALS-FTLD Complex
Morris, H. R., Waite, A. J., Williams, N. M., Neal, J., & Blake, D. J. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0268-5 · Cited by 57
Yang, C., Qiao, T., Yu, J. H., Wang, H., Guo, Y., Salameh, J. S., Metterville, J., Parsi, S., Yusuf, I. O., Brown, R. H., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0255710 · Cited by 55
Failure to Deliver and Translate—New Insights into RNA Dysregulation in ALS
Coyne, A. N., Zaepfel, B. L., & Zarnescu, D. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00243 · Cited by 62
Chen, J., Bassot, A., Giuliani, F., & Simmen, T. (2021) · Cells · doi:10.3390/cells10071789 · Cited by 58
Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43
Keating, S. S., Bademosi, A. T., Gil, R. S., & Walker, A. K. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04739-2 · Cited by 56
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
Hruška-Plocháň, M., Wiersma, V. I., Betz, K. M., Mallona, I., Ronchi, S., Maniecka, Z., Hock, E., Tantardini, E., Laferrière, F., Sahadevan, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07042-7 · Cited by 73
Self-citationBuratti, E., & Baralle, F. E. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08257.x · Cited by 56
Hazelett, D. J., Chang, J., Lakeland, D. L., & Morton, D. B. (2012) · G3 Genes Genomes Genetics · doi:10.1534/g3.112.002998 · Cited by 58
Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS
Dong, H., Xu, L., Wu, L., wang, X., Duan, W., Li, H., & Li, C. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.032 · Cited by 57
Zong, X., Tripathi, V., & Prasanth, K. V. (2011) · RNA Biology · doi:10.4161/rna.8.6.17606 · Cited by 58
Role of RNA Binding Proteins with prion-like domains in muscle and neuromuscular diseases
Picchiarelli, G., & Dupuis, L. (2020) · Cell Stress · doi:10.15698/cst2020.04.217 · Cited by 57
Lai, J. D., Berlind, J. E., Fricklas, G., Lie, C., Urenda, J., Lam, K., Maria, N. S. S., Jacobs, R. E., Yu, V. L., Zhao, Z., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.03.004 · Cited by 58
Variants Affecting Exon Skipping Contribute to Complex Traits
Lee, Y., Gamazon, E. R., Rebman, E., Lee, Y., Lee, S., Dolan, M. E., Cox, N. J., & Lussier, Y. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002998 · Cited by 56
Jovičić, A., Paul, J. W., & Gitler, A. D. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13642 · Cited by 53
Analysis of RNA-Seq Data Using TEtranscripts
Jin, Y., & Hammell, M. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7710-9_11 · Cited by 57
Amyotrophic lateral sclerosis: an update on recent genetic insights
Iguchi, Y., Katsuno, M., Ikenaka, K., Ishigaki, S., & Sobue, G. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7112-y · Cited by 56
Heat-shock protein dysregulation is associated with functional and pathological TDP-43 aggregation
Chang, H., Hou, S., Way, T., Wong, C., & Wang, I. (2013) · Nature Communications · doi:10.1038/ncomms3757 · Cited by 57
Hosokawa, M., Takeuchi, A., Tanihata, J., Iida, K., Takeda, S., & Hagiwara, M. (2019) · iScience · doi:10.1016/j.isci.2019.02.023 · Cited by 54
Ni, J., Ren, Y., Su, T., Zhou, J., Fu, C., Lu, Y., Li, D., Zhao, J., Li, Y., Zhang, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01346-0 · Cited by 51
Licht-Murava, A., Meadows, S. M., Palaguachi, F., Song, S. C., Bram, Y., Zhou, C. Q., Jackvony, S., Schwartz, R. E., Froemke, R. C., Orr, A. L., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade1282 · Cited by 54
hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS)
Salapa, H. E., Thibault, P., Libner, C. D., Ding, Y.-L., Clarke, J. P., Denomy, C., Hutchinson, C., Abidullah, H. M., Hammond, S. A., Pastushok, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44658-1 · Cited by 47
Network Analyses Reveal Novel Aspects of ALS Pathogenesis
Sanhueza, M., Chai, A., Smith, C., McCray, B. A., Simpson, T. I., Taylor, J. P., & Pennetta, G. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005107 · Cited by 53
Binding of TDP-43 to the 3′UTR of Its Cognate mRNA Enhances Its Solubility
Sun, Y., Arslan, P. E., Won, A. M., Yip, C. M., & Chakrabartty, A. (2014) · Biochemistry · doi:10.1021/bi500617x · Cited by 54
RNA Granules and Diseases: A Case Study of Stress Granules in ALS and FTLD
Fan, A. C., & Leung, A. K. L. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-29073-7_11 · Cited by 57
TDP-43 regulates cancer-associated microRNAs
Chen, X., Fan, Z., McGee, W., Chen, M., Kong, R., Wen, P., Xiao, T., Chen, X., Liu, J., Zhu, L., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0480-9 · Cited by 54
Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
Tamaki, Y., & Urushitani, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012508 · Cited by 56
RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights
Rummens, J., & Cruz, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00851-y · Cited by 62
Lauranzano, E., Pozzi, S., Pasetto, L., Stucchi, R., Massignan, T., Paolella, K., Mombrini, M., Nardo, G., Lunetta, C., Corbo, M., et al. (2015) · Brain · doi:10.1093/brain/awv005 · Cited by 52
Zaghlool, A., Ameur, A., Nyberg, L., Halvardson, J., Grabherr, M. G., Cavelier, L. B., & Feuk, L. (2013) · BMC Biotechnology · doi:10.1186/1472-6750-13-99 · Cited by 50
Studies of alternative isoforms provide insight into TDP-43 autoregulation and pathogenesis
D’Alton, S., Altshuler, M. S., & Lewis, J. M. (2015) · RNA · doi:10.1261/rna.047647.114 · Cited by 52
Old versus New Mechanisms in the Pathogenesis of ALS
Rossi, S., Cozzolino, M., & Carrı̀, M. T. (2016) · Brain Pathology · doi:10.1111/bpa.12355 · Cited by 55
Poppe, L., Rué, L., Robberecht, W., & Bosch, L. V. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.001 · Cited by 54
Medina, D. X., Orr, M. E., & Oddo, S. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.006 · Cited by 50
Disease Animal Models of TDP-43 Proteinopathy and Their Pre-Clinical Applications
Liu, Y.-C., Chiang, P., & Tsai, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020079 · Cited by 52
Dutta, K., Patel, P., Rahimian, R., Phaneuf, D., & Julien, J. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0499-2 · Cited by 52
TDP-43 Oligomerization and Phase Separation Properties Are Necessary for Autoregulation
Koehler, L. C., Grese, Z. R., Bastos, A. C. S., Mamede, L. D., Heyduk, T., & Ayala, Y. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.818655 · Cited by 51
Nguyen, T. B., Miramontes, R., Chillón-Marinas, C., Maimon, R., Vazquez‐Sanchez, S., Lau, A., McClure, N. R., Wu, Z., Wang, K. Q., England, W., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-024-01850-w · Cited by 67
Self-citationNeuronal aging causes mislocalization of splicing proteins and unchecked cellular stress
Rhine, K., Li, R., Kopalle, H., Rothamel, K. L., Ge, X., Epstein, E., Mizrahi, O., Madrigal, A. A., Her, H.-L., Gomberg, T. A., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01952-z · Cited by 59
Self-citationTDP-43 regulatesβ-adducin(Add2) transcript stability
Costessi, L., Porro, F., Iaconcig, A., & Muro, A. F. (2014) · RNA Biology · doi:10.1080/15476286.2014.996081 · Cited by 55
Amlie‐Wolf, A., Ryvkin, P., Tong, R., Dragomir, I. C., Suh, E. R., Xu, Y., Deerlin, V. M. V., Gregory, B. D., Kwong, L. K., Trojanowski, J. Q., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141836 · Cited by 57
Vatovec, S., Kovanda, A., & Rogelj, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.015 · Cited by 53
FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD
Orozco, D., & Edbauer, D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1077-2 · Cited by 52
MacNair, L., Xiao, S., Miletic, D., Ghani, M., Julien, J., Keith, J. L., Zinman, L. H., Rogaeva, E. A., & Robertson, J. (2015) · Brain · doi:10.1093/brain/awv308 · Cited by 49
Prion‐like propagation as a pathogenic principle in frontotemporal dementia
Hock, E., & Polymenidou, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13668 · Cited by 58
Self-citationKitamura, A., & Kinjo, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040964 · Cited by 56
RNA‐binding proteins involved in RNA localization and their implications in neuronal diseases
Tolino, M., Köhrmann, M., & Kiebler, M. A. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08160.x · Cited by 51
Hargus, G., Ehrlich, M., Hallmann, A.-L., & Kuhlmann, T. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1222-6 · Cited by 54
RNA-binding proteins as molecular links between cancer and neurodegeneration
Campos‐Melo, D., Droppelmann, C. A., Volkening, K., & Strong, M. J. (2014) · Biogerontology · doi:10.1007/s10522-014-9531-2 · Cited by 51
Emerging understanding of the genotype–phenotype relationship in amyotrophic lateral sclerosis
Goutman, S. A., Chen, K. S., Paez-Colasante, X., & Feldman, E. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00039-9 · Cited by 50
Funikov, S. Y., Rezvykh, A. P., Mazin, P., Morozov, A. V., Maltsev, A. V., Chicheva, M. M., Vikhareva, E. A., Евгеньев, М. Б., & Ustyugov, A. A. (2018) · Neurogenetics · doi:10.1007/s10048-018-0553-9 · Cited by 53
The Role of Transposable Elements of the Human Genome in Neuronal Function and Pathology
Chesnokova, E., Beletskiy, A., & Kolosov, P. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105847 · Cited by 51
Kapeli, K., & Yeo, G. W.-M. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00144 · Cited by 50
Self-citation
Metadata
- Authors
- Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C., Kordasiewicz, H., Sedaghat, Y., Donohue, J. P., Shiue, L., Bennett, C. F., Yeo, G. W., & Cleveland, D. W.
- Affiliations
- University of California San Diego (US)
- Ionis Pharmaceuticals (United States) (US)
- University of California, Santa Cruz (US)
- Corresponding author
- Yeo, Gene W
- Cleveland, Don W
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2011-02-27
- Volume
- 14
- Issue
- 4
- Pages
- 459-468
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC3094729
- OpenAlex
- W2101042581
- Cited by
- 1,335
- References
- 51
- Citations by year
- 2026: 71 · 2025: 112 · 2024: 116 · 2023: 84 · 2022: 76 · 2021: 85 · 2020: 74 · 2019: 85 · 2018: 84 · 2017: 83 · 2016: 72 · 2015: 78 · 2014: 79 · 2013: 86 · 2012: 99
- FWCI
- 63.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust (089701)
- National Human Genome Research Institute (HG004659, R01HG004659)
- National Institute of General Medical Sciences (R01GM084317, GM084317)
- National Institute of Neurological Disorders and Stroke (R37 NS 27036, R37NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- TDP-43, amyotrophic lateral sclerosis, RNA-binding proteins, RNA splicing, long introns, neuronal vulnerability, nonsense-mediated mRNA decay, 3' untranslated region, progranulin, sortilin, FUS, synaptic proteins, antisense oligonucleotides, brain transcriptome, neurodegeneration
- MeSH terms
- Amyotrophic Lateral Sclerosis, Animals, DNA-Binding Proteins, Female, Homeostasis, Humans, Mice, Inbred C57BL, Mice, Transgenic, Nerve Degeneration, Neurons, RNA Precursors, RNA, Messenger, Oligonucleotides, Antisense, Alternative Splicing, 3' Untranslated Regions, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review